[1]
2017. Prevention of acute kidney injury in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention: comparison of atorva­­statin and rosuvastatin in «case – control» study. Ukrainian Journal of Cardiology. 1 (Mar. 2017), 16–24.